Ciara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
23andMe Holding Co. ME, +0.39% said Tuesday it’s launching a health action plan that will offer its clients personalized recommendations based on genetic and other health data. The South San Francisco-based provider of home DNA kits said the plan will offer suggestions on modifying behavior related to sleep, diet and exercise, as well as on potential new treatments or activities for certain health conditions.
It will also dig into health data, such as diagnoses or family history, to further personalize recommendations. “Eligible customers may also receive recommendations for further clinical action, like getting a blood test, which can now be coordinated directly through 23andMe,” the company said in a statement. The stock was up 2% premarket but has fallen 64% in the year to date, while the S&P 500 SPX, +1.20% has gained 8.5%.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
The MarketWatch 50 - Lina Khan - MarketWatchThe MarketWatch 50 - Lina Khan.
Leer más »
Amgen’s stock jumps premarket after earnings beat and company again raises guidanceCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Leer más »
S&P Global upgrades Ford’s rating and restores it to investment gradeCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Leer más »
Sensata Technologies on track to achieve goal of $2 billion from electrification by 2026Ciara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Leer más »
GE HealthCare beats Q3 profit estimatesCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Leer más »
Carl Icahn’s investing arm’s stock falls to 19-year lowCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Leer más »